News on Medial

Israel's Coralogix raises $115 Mn to fuel India expansion

EntrackrEntrackr · 1m ago
Israel's Coralogix raises $115 Mn to fuel India expansion
Medial

Snippets Israel's Coralogix raises $115 Mn to fuel India expansion This expansion follows Coralogix’s acquisition of Aporia in December 2024 and the launch of its Coralogix AI Center, which focuses on the performance, security, and governance of enterprise data. Israel-based cybersecurity company Coralogix has raised $115 million in its Series E round led by NewView Capital and included participation from Canada Pension Plan Investment Board and NextEquity. The funding values Coralogix at over $1 billion. All existing investors, Advent International, Brighton Park Capital, Revaia, Greenfield Partners, Red Dot Capital Partners, O.G. Tech, Joule Capital Partners, and Maor Investments, supported this funding round. The proceeds will be used to expand its office in Gurugram and hire more people in Bengaluru and Mumbai. It will recruit for roles in data science, AI, customer engineering, and enterprise sales. The expansion aims to serve sectors like BFSI, IT, telecom, logistics, and edtech in India. Coralogix offers a full-stack platform for application performance, security, and real-user monitoring. It prices its service by data volume and provides strong support to help businesses respond quickly and resolve issues. Coralogix already works with companies in India, including Postman, Meesho, BookMyShow, Razorpay, CoinDCX, BharatPe, and Delhivery. It plans to launch Olly, its new AI observability tool, to help businesses find and resolve issues quickly and meet compliance requirements.

Related News

Redcliffe Labs raises $42 Mn in Series C round

EntrackrEntrackr · 10m ago
Redcliffe Labs raises $42 Mn in Series C round
Medial

Omnichannel diagnostics service provider Redcliffe Labs has raised $42 million in a Series C funding round led by Denmark-based investment firm IFU, which contributed $20 million. Existing investor LeapFrog added $15 million, while the remaining capital came from shareholders HealthQuad and Spark Growth Ventures. This new funding follows the Noida-based company’s previous rounds, including $61 million in its Series B in May 2022 and $10 million in Series A in April 2021. Other notable investors include Schroders, LC Nueva, Chiratae Ventures, and Alkemi Venture Partners. The fresh capital will fuel Redcliffe’s expansion plans, particularly in deepening its presence in tier II and III cities across India. The company plans to open more labs and collection centers and expand its home collection network, according to a press release. Redcliffe has executed strategic acquisitions in North-Western India and continues to pursue PAN-India expansion through partnerships and further acquisitions. In addition to its financial growth, Redcliffe has strengthened its leadership. Ankur Shah, former chief finance and strategy officer of Careem (acquired by Uber), has joined as an independent director. Alka Saxena, formerly of Health Care at Home and Dr. Lal PathLabs, has been appointed as CFO. Currently, Redcliffe Labs’ services are available in more than 220 cities across India through a network of 80 labs, over 2,000 collection centers, and home collection services. The company claims to have served more than 7 million patients across tier I, II, and III cities. Redcliffe Labs’ operating revenue surged 2.6 times to Rs 347 crore in FY23, up from Rs 130 crore in FY22. However, the company’s losses jumped fivefold to Rs 345.6 crore from Rs 67.7 crore over the same period. It competes with notable players such as PharmEasy-owned Thyrocare, Healthians, 1mg, and Dr. Lal PathLabs.

Download the medial app to read full posts, comements and news.